Works matching IS 10834389 AND DT 2022 AND VI 27 AND IP 5
Results: 16
Effect of Helicobacter pylori on immunotherapy is gaining more attention.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12925
- By:
- Publication type:
- Article
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12924
- By:
- Publication type:
- Article
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12923
- By:
- Publication type:
- Article
Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12922
- By:
- Publication type:
- Article
Long‐term changes in aberrant DNA methylation and gastritis after Helicobacter pylori eradication focused on metachronous gastric cancer.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12915
- By:
- Publication type:
- Article
Helicobacter pylori results in lysis and death after exposure to water.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12921
- By:
- Publication type:
- Article
A 15‐year review of Helicobacter pylori screening and treatment among United States Veterans.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12919
- By:
- Publication type:
- Article
Eradication rate and safety of a "simplified rescue therapy": 14‐day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real‐world, retrospective clinical study in China
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12918
- By:
- Publication type:
- Article
Constitutive programmed death ligand 1 expression protects gastric G‐cells from Helicobacter pylori–induced inflammation.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12917
- By:
- Publication type:
- Article
Achieving Helicobacter pylori eradication in the primary treatment requires a deep integration of personalization and standardization.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12916
- By:
- Publication type:
- Article
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12920
- By:
- Publication type:
- Article
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross‐sectional survey and meta‐analysis.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12914
- By:
- Publication type:
- Article
New insight on the role of Helicobacter pylori cagA in the expression of cell surface antigens with important biological functions in gastric carcinogenesis.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12913
- By:
- Publication type:
- Article
Low compliance to post‐screening recommendations in a family‐based Helicobacter pylori screening and treatment program: A prospective cohort study.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12912
- By:
- Publication type:
- Article
CORRIGENDUM.
- Published in:
- 2022
- Publication type:
- Correction Notice
Issue Information.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12822
- Publication type:
- Article